Company Oasmia Pharmaceutical AB NORDIC GROWTH MARKET
Equities
OASM
SE0000722365
Pharmaceuticals
Business Summary
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
European Union
100.0
%
| - | - | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 66 | 23/23/23 |
Robert Maiorana
DFI | Director of Finance/CFO | 64 | 01/20/01 |
Heidi Ramstad
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/21/01 |
Johanna Röstin
LAW | General Counsel | 57 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 19/19/19 | |
Hege Hellstrom
BRD | Director/Board Member | 59 | 26/19/26 |
Pål Ryfors
BRD | Director/Board Member | 41 | 25/22/25 |
Roger Tell
BRD | Director/Board Member | 59 | 25/22/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 538,043,455 | 330,469,658 ( 61.42 %) | 0 | 61.42 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |